These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 12495882)
1. [Evaluation of platinum contamination of a hazardous drug preparation area in a hospital pharmacy]. Leboucher G; Serratrice F; Bertholle V; Thore L; Bost M Bull Cancer; 2002 Nov; 89(11):949-55. PubMed ID: 12495882 [TBL] [Abstract][Full Text] [Related]
2. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment. Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696 [TBL] [Abstract][Full Text] [Related]
3. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device. Siderov J; Kirsa S; McLauchlan R J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949 [TBL] [Abstract][Full Text] [Related]
4. Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden. Hedmer M; Georgiadi A; Bremberg ER; Jönsson BA; Eksborg S Ann Occup Hyg; 2005 Oct; 49(7):629-37. PubMed ID: 16126760 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of surface contamination in a hospital hematology--oncology pharmacy. Touzin K; Bussières JF; Langlois E; Lefebvre M J Oncol Pharm Pract; 2009 Mar; 15(1):53-61. PubMed ID: 18772214 [TBL] [Abstract][Full Text] [Related]
6. Environmental and biological monitoring of platinum-containing drugs in two hospital pharmacies using positive air pressure isolators. Kopp B; Crauste-Manciet S; Guibert A; Mourier W; Guerrault-Moro MN; Ferrari S; Jomier JY; Brossard D; Schierl R Ann Occup Hyg; 2013 Apr; 57(3):374-83. PubMed ID: 23091112 [TBL] [Abstract][Full Text] [Related]
7. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757 [TBL] [Abstract][Full Text] [Related]
8. Association of surface contamination by antineoplastic drugs with different working conditions in hospital pharmacies. Odraska P; Dolezalova L; Kuta J; Oravec M; Piler P; Synek S; Blaha L Arch Environ Occup Health; 2014; 69(3):148-58. PubMed ID: 24325745 [TBL] [Abstract][Full Text] [Related]
10. Exposure to antineoplastic drugs in two UK hospital pharmacy units. Mason HJ; Blair S; Sams C; Jones K; Garfitt SJ; Cuschieri MJ; Baxter PJ Ann Occup Hyg; 2005 Oct; 49(7):603-10. PubMed ID: 15964878 [TBL] [Abstract][Full Text] [Related]
11. Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry. Brouwers EE; Huitema AD; Bakker EN; Douma JW; Schimmel KJ; van Weringh G; de Wolf PJ; Schellens JH; Beijnen JH Int Arch Occup Environ Health; 2007 Aug; 80(8):689-99. PubMed ID: 17377802 [TBL] [Abstract][Full Text] [Related]
12. Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective Phase III. Bigelow S; Schulz H; Dobish R; Chambers CR J Oncol Pharm Pract; 2009 Sep; 15(3):157-60. PubMed ID: 19171554 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy of additional measures introduced for the protection of healthcare personnel handling antineoplastic drugs. Odraska P; Dolezalova L; Kuta J; Oravec M; Piler P; Blaha L Ann Occup Hyg; 2013 Mar; 57(2):240-50. PubMed ID: 22926784 [TBL] [Abstract][Full Text] [Related]
14. A case study: surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals. Acampora A; Castiglia L; Miraglia N; Pieri M; Soave C; Liotti F; Sannolo N Ann Occup Hyg; 2005 Oct; 49(7):611-8. PubMed ID: 15964876 [TBL] [Abstract][Full Text] [Related]
15. Contamination of syringe plungers during the sampling of cyclophosphamide solutions. Favier B; Gilles L; Latour JF; Desage M; Giammarile F J Oncol Pharm Pract; 2005 Mar; 11(1):1-5. PubMed ID: 16460597 [TBL] [Abstract][Full Text] [Related]
16. Sampling for airborne fluorouracil in a hospital drug preparation area. McDiarmid MA; Egan T; Furio M; Bonacci M; Watts SR Am J Hosp Pharm; 1986 Aug; 43(8):1942-5. PubMed ID: 3752134 [TBL] [Abstract][Full Text] [Related]
17. Guidance values for surface monitoring of antineoplastic drugs in German pharmacies. Schierl R; Böhlandt A; Nowak D Ann Occup Hyg; 2009 Oct; 53(7):703-11. PubMed ID: 19620232 [TBL] [Abstract][Full Text] [Related]
18. Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo. Schierl R; Masini C; Groeneveld S; Fischer E; Böhlandt A; Rosini V; Paolucci D J Oncol Pharm Pract; 2016 Feb; 22(1):37-45. PubMed ID: 25227229 [TBL] [Abstract][Full Text] [Related]
19. Hazardous anticancer drugs in health care: environmental exposure assessment. Connor TH Ann N Y Acad Sci; 2006 Sep; 1076():615-23. PubMed ID: 17119238 [TBL] [Abstract][Full Text] [Related]
20. Determination of platinum surface contamination in veterinary and human oncology centres using inductively coupled plasma mass spectrometry. Janssens T; Brouwers EE; de Vos JP; de Vries N; Schellens JH; Beijnen JH Vet Comp Oncol; 2015 Sep; 13(3):305-13. PubMed ID: 24034226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]